|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 179.89 USD | +1.73% |
|
+6.50% | +43.23% |
| 04:59pm | Mirum Pharmaceuticals' Bluejay Acquisition Expands Liver Disease Pipeline, Morgan Stanley Says | MT |
| 04:46pm | SLM Shares Fall After Downgrades From Morgan Stanley, Compass Point | MT |
Main competitors
| Dividend Yield (Y) | Dividend Yield (Y+1) | P/E (Y) | Price to Book (Y) | EV / Sales (Y) | EV / EBITDA (Y) | EV / EBIT (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|
| 2.18% | 2.38% | 17.84x | 2.79x | 7.26x | - | 24.21x | 281B | ||
| 1.6% | 1.9% | 17.8x | 2.42x | 10.86x | - | 28.58x | 272B | ||
| 2.13% | 2.31% | 14.3x | 0.99x | - | - | - | 195B | ||
| 1.15% | 1.31% | 20.38x | 3.63x | - | - | - | 168B | ||
| 2.38% | 2.69% | 14.72x | 1.39x | 1.39x | - | 2.87x | 58.82B | ||
| 1.4% | 1.49% | 14.32x | 2.65x | - | - | - | 32.29B | ||
| 0.34% | 0.37% | 33.8x | 5.43x | 2.15x | 14.23x | 25.49x | 29.49B | ||
| 2.41% | 2.74% | 12.15x | 1.1x | 6.42x | - | 14.99x | 27.4B | ||
| 3.04% | 3.39% | 9.81x | 0.77x | - | - | - | 25.82B | ||
| 4.01% | 4.01% | 10.01x | 0.98x | 6.22x | - | 22.44x | 22.93B | ||
| 2.51% | 3.14% | 12.51x | 1.13x | 11.75x | - | 22.65x | 20.16B | ||
| 3.19% | 3.56% | 13.15x | 1.21x | - | - | - | 19.53B | ||
| 1.64% | 1.85% | 11.38x | 0.77x | 8.46x | - | 21.7x | 19.07B | ||
| 1.76% | 2.28% | 16.36x | 1.18x | - | - | - | 17.82B | ||
| 3.45% | 4.25% | 16.85x | 1.47x | 4.58x | - | 11.16x | 15.98B | ||
| 1.46% | 1.61% | 20.91x | 2.53x | 2.03x | 11.62x | 11.02x | 12.8B | ||
| 1.04% | 1.08% | 25.89x | 6.47x | 3.25x | 15.26x | 15.78x | 12.76B | ||
| 2.72% | 2.86% | 19.79x | 1.18x | 4.41x | 27.84x | 33.94x | 12.18B | ||
| 4.25% | 4.4% | 12.09x | 1.1x | 0.46x | - | 3.53x | 11.72B | ||
| Average | 2.25% | 2.51% | 16.53x | 2.06x | 5.33x | 17.24x | 18.33x | 66.01B | |
| Weighted average by Cap. | 1.94% | 2.17% | 17.11x | 2.31x | 7.60x | 16.40x | 22.94x |
- Stock Market
- Equities
- MS Stock
- Sector Morgan Stanley
- Sector dividends
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition
















